InvestorsHub Logo
Followers 3
Posts 1687
Boards Moderated 0
Alias Born 03/15/2018

Re: Kevin20 post# 33679

Thursday, 03/31/2022 11:25:05 AM

Thursday, March 31, 2022 11:25:05 AM

Post# of 34627
There's a constant flux of new investor's. i.e. According to this list of Lexaria's Institutional Holdings, Invenomic Capital management currently owns 359,113 shares.

https://www.nasdaq.com/market-activity/stocks/lexx/institutional-holdings

I imagine that as the hopefully good news on FDA phases 1 and 2 are announced for the CBD indications for NDI's that the new institutional investors action should heat up. I would have liked to see things happen faster just like anyone but the groups with the big bucks are the ones controlling the SP and obviously the move to Big Pharma is a longer road than making puny royalty deals with Mom and Pop shops.

As far as a company partnering up with Lexaria, this would be the worst time for that with the SP at ATL. Better to give a partner 10% of the company at 100M cap than 50% of the company at 20M cap.

Definitely feeling positive for the coming year.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LEXX News